Female survival advantage was generally absent or reversed after developing stage 5 chronic kidney disease (CKD), wrote authors of research published in JAMA Internal Medicine. The authors’ findings suggest that differences in treatment…
Women With Stage 5 CKD Less Likely to Survive, Receive Kidney Replacement Therapy Than Men
